Anti-malarial market and policy surveys in sub-Saharan Africa

摘要: At a recent meeting (Sept 18, 2009) in which reasons for the limited access to artemisinin-based combination therapy (ACT) sub-Saharan Africa were discussed, policy and market surveys on anti-malarial drug availability accessibility Burundi Sierra Leone presented highly interactive brainstorming session among key stakeholders across private, public, not-for-profit sectors. The surveys, conduct of directly involved national malaria control programme managers two countries, provides groundwork evidence-based implementation. results could be extrapolated other countries with similar socio-demographic profiles. resulted recommendations actions taken at global, national, community level better ACT accessibility. global level, both public private sectors have take strengthen policies that lead replacement loose blister packs fixed-dose products, develop strategies ban inappropriate anti-malarials regulate those bans, facilitate technology knowledge transfer scale up production should readily available affordable patients who are greatest need these medicines. medicines enacted enforced. sector, including funding donors, participate ensuring sector is engaged implementation process. Research discussed important evaluate right incentives local level. outreach education about appropriate preventive treatment measures must continue strengthened, service delivery systems developed within sectors, measures, decrease ineffective What was clear during continuing commitment, strengthened interaction transparency various stakeholders, focus communities, governments, action only way sustainably address malaria, disease continues significant health socio-economic impact worldwide, particularly Africa. Details methodology employed carrying out studies this meeting, as well more detailed results, data analysis discussion soon published.